WOLF — Grey Wolf Animal Health Share Price
0.000.00%
Last trade - 00:00- CA$30.77m
- CA$51.96m
- CA$26.83m
- 59
- 55
- 74
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.07 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 25.38 | ||
| Price to Sales | 1.15 | ||
| EV to EBITDA | 15.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.21% | ||
| Return on Equity | 2.61% | ||
| Operating Margin | 7.1% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 13.1 | 22.64 | 25.41 | 26.83 | n/a | n/a | 27.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -76.03 | +4.94 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Grey Wolf Animal Health Corp. is a Canadian diversified animal health company. The Company markets a portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company operates two business units: Animal Health business unit and Pharmacy business unit. The Animal Health business unit focuses on sourcing, in-licensing, acquiring, and commercializing branded and generic pharmaceutical, nutraceutical, and consumable products for use in veterinary clinics across Canada. The Pharmacy business unit compounds pharmaceuticals, primarily for animal and human use, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animal product category includes pharmaceuticals, wound care, nutraceuticals and disposables. Its equine health products include SUCCEED Digestive Conditioning Program, SUCCEED Equine Fecal Blood Test and Equi-Tape.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 9th, 2021
- Public Since
- June 17th, 2021
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 34,192,334
- Address
- 100 King St. W., Toronto, M5X 1E2
- Web
- https://greywolfah.com/
- Phone
- +1 4164812222
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for WOLF
Q1 2025 Grey Wolf Animal Health Corp Earnings Release
Grey Wolf Animal Health Corp Annual Shareholders Meeting
Q2 2025 Grey Wolf Animal Health Corp Earnings Release
Similar to WOLF
BuildDirect.com Technologies
TSX Venture Exchange
Reitmans Canada
TSX Venture Exchange
FAQ
What is the Grey Wolf Animal Health share price?
As of Today at 20:57 UTC, shares in Grey Wolf Animal Health are trading at CA$0.90. This share price information is delayed by 15 minutes.
How has the Grey Wolf Animal Health share price performed this year?
Shares in Grey Wolf Animal Health last closed at CA$0.90 and the price had moved by +23.29% over the past 365 days. In terms of relative price strength the Grey Wolf Animal Health share price has outperformed the Toronto Stock Exchange 300 Composite Index by +9.61% over the past year.
What are the analyst and broker recommendations for Grey Wolf Animal Health?
There is no consensus recommendation for this security.
Find out moreWhat is the Grey Wolf Animal Health dividend yield?
Grey Wolf Animal Health does not currently pay a dividend.
Does Grey Wolf Animal Health pay a dividend?
Grey Wolf Animal Health does not currently pay a dividend.
When does Grey Wolf Animal Health next pay dividends?
Grey Wolf Animal Health does not currently pay a dividend.
How do I buy Grey Wolf Animal Health shares?
To buy shares in Grey Wolf Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Grey Wolf Animal Health?
As of the previous close price of CA$0.90, shares in Grey Wolf Animal Health had a market capitalisation of CA$30.77m.
Where are Grey Wolf Animal Health shares listed?
Here are the trading details for Grey Wolf Animal Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: WOLF
What kind of share is Grey Wolf Animal Health?
Based on an overall assessment of its quality, value and momentum Grey Wolf Animal Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Grey Wolf Animal Health share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Grey Wolf Animal Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Grey Wolf Animal Health. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +11.84%.
As of the last closing price of CA$0.90, shares in Grey Wolf Animal Health were trading +3.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Grey Wolf Animal Health PE Ratio?
The Grey Wolf Animal Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Grey Wolf Animal Health?
We do not have data on Grey Wolf Animal Health's directors